Cancer

Rakovina Therapeutics Provides Update on Previously Announced Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Rakovina…

6 months ago

TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology…

6 months ago

Media Invited to Science Webinar on Projects Launching to Space Station on Northrop Grumman’s Cygnus Spacecraft

KENNEDY SPACE CENTER, Fla., July 22, 2024 /PRNewswire/ -- The International Space Station (ISS) National Laboratory will host a science…

6 months ago

Relentless Health to Partner With Firefighters to Deliver PFAS Testing

Relentless Health (formerly Diagnose Early) is partnering with the Professional Firefighters Association of South Carolina (PFFASC) to deliver at-home PFAS…

6 months ago

Varian Announces Powerful Functionality, Expanding Versatility and Connectivity for its Ethos Adaptive Radiotherapy System

Technology Upgrades Remove Complexity to Enable Wider Access to Highly Personalized Cancer Care PALO ALTO, Calif., July 22, 2024 /PRNewswire/…

6 months ago

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine’s Drug Resistance

New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL /…

6 months ago

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany…

6 months ago

Navigating the Radiological Landscape: Insights into Radiotherapy and Nuclear Medicine Markets

Advancements in AI (Artificial Intelligence) technology is poised to revolutionize radiotherapy, enhancing patient outcomes, and streamlining clinical workflows. Meanwhile, the…

6 months ago

Cell BioEngines Secures an Additional $2 Million in Funding From SOSV and the Empire State Development’s New York Ventures

NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a New York, USA-based company researching stem cells in…

6 months ago